Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/153832
Title: LRG1 promotes metastatic dissemination of melanoma through regulating EGFR/STAT3 signalling
Authors: Kwan, Yuet Ping
Teo, Melissa Hui Yen
Lim, Jonathan Chee Woei
Tan, Michelle Siying
Rosellinny, Graciella
Wahli, Walter
Wang, Xiaomeng
Keywords: Science::Medicine
Issue Date: 2021
Source: Kwan, Y. P., Teo, M. H. Y., Lim, J. C. W., Tan, M. S., Rosellinny, G., Wahli, W. & Wang, X. (2021). LRG1 promotes metastatic dissemination of melanoma through regulating EGFR/STAT3 signalling. Cancers, 13(13), 3279-. https://dx.doi.org/10.3390/cancers13133279
Project: MOE2014-T2-1- 036 
NMRC/OFLCG/001/2017 
NMRC/OFLCG/004/2018 
Journal: Cancers 
Abstract: Although less common, melanoma is the deadliest form of skin cancer largely due to its highly metastatic nature. Currently, there are limited treatment options for metastatic melanoma and many of them could cause serious side effects. A better understanding of the molecular mechanisms underlying the complex disease pathophysiology of metastatic melanoma may lead to the identification of novel therapeutic targets and facilitate the development of targeted therapeutics. In this study, we investigated the role of leucine-rich α-2-glycoprotein 1 (LRG1) in melanoma development and progression. We first established the association between LRG1 and melanoma in both human patient biopsies and mouse melanoma cell lines and revealed a significant induction of LRG1 expression in metastatic melanoma cells. We then showed no change in tumour cell growth, proliferation, and angiogenesis in the absence of the host Lrg1. On the other hand, there was reduced melanoma cell metastasis to the lungs in Lrg1-deficient mice. This observation was supported by the promoting effect of LRG1 in melanoma cell migration, invasion, and adhesion. Mechanistically, LRG1 mediates melanoma cell invasiveness in an EGFR/STAT3-dependent manner. Taken together, our studies provided compelling evidence that LRG1 is required for melanoma metastasis but not growth. Targeting LRG1 may offer an alternative strategy to control malignant melanoma.
URI: https://hdl.handle.net/10356/153832
ISSN: 2072-6694
DOI: 10.3390/cancers13133279
Rights: © 2021 The Author(s). Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles

Files in This Item:
File Description SizeFormat 
cancers-13-03279.pdf24.57 MBAdobe PDFView/Open

Page view(s)

16
Updated on May 20, 2022

Download(s)

5
Updated on May 20, 2022

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.